Back
National Research Vs. GoodRx Holdings Industry Stock Comparison
Sell
46
NRC
National Research
Last Price:
29.66
Seasonality Move:
10.83%
Buy
68
GDRX
GoodRx Holdings
Last Price:
7.61
Seasonality Move:
14.62%
Sell
46
National Research (NRC)
is a Sell
Is National Research a Buy, Sell or Hold?
- The current National Research [NRC] share price is $35.71. The Score for NRC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- NRC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
GoodRx Holdings (GDRX)
is a Buy
Is GoodRx Holdings a Buy, Sell or Hold?
- The current GoodRx Holdings [GDRX] share price is $7.51. The Score for GDRX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GDRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NRC Stock Price Chart
What is National Research's stock price today?
-
The National Research share price today is $35.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRC is experiencing buying pressure, which is a positive indicator for future bullish movement.
GDRX Stock Price Chart
What is GoodRx Holdings's stock price today?
-
The GoodRx Holdings share price today is $7.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDRX is experiencing slight buying pressure.
NRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 52.46 | Buy |
| Chaikin Money Flow: | 36993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.62 - 36.06) | Buy |
| Bollinger Bands (100): | (36.08 - 40.64) | Sell |
GDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 65.75 | Buy |
| Chaikin Money Flow: | 89356 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.65 - 7.17) | Buy |
| Bollinger Bands (100): | (6.16 - 7.18) | Buy |
NRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.72 | Buy |
| 20-day SMA: | 34.32 | Buy |
| 50-day SMA: | 37.38 | Sell |
| 200-day SMA: | 40.7 | Sell |
| 8-day EMA: | 34.89 | Buy |
| 20-day EMA: | 35.06 | Buy |
| 50-day EMA: | 36.55 | Sell |
| 200-day EMA: | 39.67 | Sell |
GDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.19 | Buy |
| 20-day SMA: | 6.95 | Buy |
| 50-day SMA: | 7.02 | Buy |
| 200-day SMA: | 6.37 | Buy |
| 8-day EMA: | 7.21 | Buy |
| 20-day EMA: | 7.04 | Buy |
| 50-day EMA: | 6.9 | Buy |
| 200-day EMA: | 6.55 | Buy |
National Research Earnings Growth & NRC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
GoodRx Holdings Earnings Growth & GDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.09 per share, and an increase next year of $0.09 per share.
National Research Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
GoodRx Holdings Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||